Cell adhesion inhibitors

Details Cell adhesion inhibitors Cell adhesion inhibitors

2006-02-21

2006-02-21

McKane, Joseph K. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

C514S613000, C564S123000

Reexamination Certificate

active

07001921

ABSTRACT:
The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.

REFERENCES:
patent: 4725583 (1988-02-01), Luly et al.
patent: 4826815 (1989-05-01), Luly et al.
patent: 5260277 (1993-11-01), McKenzie
patent: 5314902 (1994-05-01), Tjoeng et al.
patent: 5399570 (1995-03-01), Klingler et al.
patent: 5434188 (1995-07-01), Boschelli et al.
patent: 0 460 679 (1991-12-01), None
patent: 0 519 748 (1992-12-01), None
patent: 0 565 896 (1993-10-01), None
patent: WO 92 00995 (1991-07-01), None
patent: WO 92 08464 (1991-11-01), None
patent: WO 93 08823 (1991-11-01), None
patent: WO 93 09795 (1993-05-01), None
patent: WO 94 02445 (1993-07-01), None
patent: WO 94 15958 (1994-01-01), None
patent: WO 94 23714 (1994-10-01), None
patent: WO 95 15973 (1994-12-01), None
“Reach-through Claims”, Baker Botts LLP/News & Events/ In Print, Apr. 12, 2002, htp://www.bakerbotts.com
ews.
Abraham, W.M., et al., “α4-Intergrins Mediate Antigen-induced Late Bronchial Responses and Prolonged Airway Hyperresponsiveness in Sheep”, J. Clin. Invest., 93, pp. 776-787 (1994).
Baldwin, J.E., et al., CA 108: 127408t, 1998.
Chen, S.T., et al., CA 115:159749r, 1991.
Chisolm, P.L., et al., “Monoclonal Antibodies to the Integrin α-4 Subunit Inhibit the Murine contact Hypersensitivity Response,” Eur. J. Immunol., 23, pp. 682-688 (1993).
Elices, M.J., et al., “Expression and functional Significance of Alternatively Spliced CS1 Fibronectin in Rheumatoid Arthritis Microvasculature,”, J. Chin. Invest., 93, pp. 405-416 (1994).
Ferguson, T.A., et al., “Two Integrin-binding Peptides Abrogate T Cell-Mediated Immune Responses in Vivo”, Proc. Natl. Acad. Sci. USA, 88, pp. 8072-8075 (1991).
Ferguson, T.A. and T.S. Kupper, “Antigen-Independent Processes in Antigen-Specific Immunity”, J. Immunol., 150, pp. 117-1182 (1993).
Greenstein et al., Synthesis and Activity of NacSerAspLysPro Analoguesnon Cellular Interactions Between T-Cell and Erythrocytes in Rosette Formation:, J. Med. Chem. 1998, 33, 2122-2127.
Goodman et al., “Synthesis and Conformation of Sequential Polypeptides of L-Alanine and Beta-Aminobutyric Acid”, Macromolecules, 9:1-6, 1976.
Gruszecki, W., et al., “Diacylamines—Perfect Acylating Agents for Peptide Synthesis”, Liebigs Ann. Chem., p 331-336, 1988.
Helmer, M.E., “VLA Proteins in the Integrin Family: Structures, Functions, and their Role in Leukocytes”, Ann. Rev. Immunol., 8, pp. 365-400 (1990).
Jiang, J., et al., “Approaches Toward the Total Synthesis of Astins A, B, and C”, Tet. Let., 35(14), pp 2121-2124, 1994.
Jiang et al., “Synthesis and Conformation of Sequential Polypeptides of L-Alanine and Beta-Aminobutyric Acid”, Tetrahedron Letters, 35:2121-4, 1994.
Kim et al., “Inhibition of123I-Labeled Ristocetin Binding toMicrococcus luteuscells by the Peptides Related to Bacterial Cell Wall Mucopeptide Precursors: Quantitative Structure-Activity Relationships”, J. Med. Chem., 1989, 32, 84-93.
Komoriya, A., et al., “The Minimal Essential Sequence for a Major Cell Type-specific Adhesion Site (CSI) ithin the Alternatively spliced Type III Connecting Segment Domain of Fibronectin is Leucine-Aspartic Acid-Valine”, J. Biol. Chem., 266, pp. 15075-15079 (1991).
Lampi, K.J., et al., CA 118:73514t, 1993.
Lobb, R.R. and Hemler, M.E., “The Pathophysiologic Role of α4 Integrins In Vivo”, J. Clin. Invest., 94, pp. 1722-1728 (1994).
Molossi, S., et al., “Blockade of Very Late Antigen-4 Integrin Binding to Fibronectin with Connecting Segment-1 Peptide Reduces Accelerated Coronary Arteriopathy in Rabbit Cardiac Allografts”, J. Clin. Invest., 95, pp. 2601-2610 (1995).
Morales-Ducret, J., et al., “α4/β1 Integrin (VLA-4) Ligands in Arthritis”, J. Immunol., 149, pp. 1424-1431 (1992).
Nowlin, D.M., “A Novel Cyclic Peptide Inhibits α4β1 and α5β1 Integrin-mediated Cell Adhesion”, J. Biol. Chem., 268, pp. 20352-20359 (1993).
Subasinghe et al., “Synthesis and Acyclic and Dehydroaspartic Acid Analogues of Ac-Asp-Glu-OH and Their Inhibition of Rat Brain N-Acetylated Alpha-Linked Acidic Dipeptidase (NAALA Dipeptidase)”, Journal of Medicinal Chemistry, 33:2734-2744, 1990.
Thierry et al., “Synthesis and Activity of NacSerAspLysPro Analogues on Cellular Interactions between T-Cell and Erythrocytes in Rosette Formation”, J. Med. Chem. 1990, 33, 2122-2127.
Wayner, E.A. and Kovach, N.L., “Activation-dependent Recognition by Hematopoietic Cells of the LDV Sequence in the V Region of Fibronectin”, J. Cell. Biol., 116, pp. 489-497 (1992).
Yednock, T.A., et al., “Prevention of Experimental Autoimmune Encephalomyelitis by Antibodies Against α4β1 Integrin”, Nature, 356, pp. 63-66 (1992).

Affiliated with

Also associated with

Rating

Cell adhesion inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell adhesion inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell adhesion inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3659743